Wei Zhu, General manager of Nanjing Aoke Immunity, graduated from Nankai University with a master's degree in Biochemistry and molecular biology. He has 20 years of experience in production process development and industrialization in the biomedical industry, and has completed several IND and BLA project management work for antibody drugs. I have rich experience in the production process requirements and industrialization process of antibody drug GMP workshop. He worked in Shanghai Saijin Bio-Pharmaceutical Co., LTD., successively as production manager, product development center manager, technical director and project director. Responsible for the company's product process development, clinical sample preparation and trial production, as well as the specific technical implementation and project docking of foreign cooperation projects, during which the successful completion of several antibody drug CDMO project cooperation. In 2011, he served as deputy general manager and Vice president of Operations of Biaotai Biopharmaceutical Co., LTD., responsible for the development and industrialization of antibody drug process. During this period, I completed several antibody drug process development, production technology transfer and commercial production, and led the company's industrialization base construction and product project management and operation. In 2022, he served as the general manager of Zhejiang Huahai Biotechnology Co., LTD., responsible for the daily management and operation of the company. He has served as senior Vice president and general manager of Nanjing CMC since 2023, responsible for the company's CMC team building and related business development, and responsible for the daily management of the company.